Figures & data
Figure 1 Schematic to show effects of inhaled corticosteroid (ICS) moiety of single triple inhaler therapy in COPD.
![Figure 1 Schematic to show effects of inhaled corticosteroid (ICS) moiety of single triple inhaler therapy in COPD.](/cms/asset/cc765566-a12d-4d1a-b1d4-14c0de32c137/dcop_a_177333_f0001_c.jpg)
Table 1 Key trials of single triple inhaler ICS/LABA/LAMA vs dual inhalers as either ICS/LABA or LABA/LAMA
Figure 2 Duration of lung retention with inhaled corticosteroids due to relative lipophilicity, which in turn determines pneumonia risk in COPD.
Abbreviation: 17-BMP, 17-beclometasone monopropionate.
![Figure 2 Duration of lung retention with inhaled corticosteroids due to relative lipophilicity, which in turn determines pneumonia risk in COPD.](/cms/asset/022b57c9-907b-42ee-889c-be6b2e6ac492/dcop_a_177333_f0002_c.jpg)